Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT05814627

Public ClinicalTrials.gov record NCT05814627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 6:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and Who Had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Rheumatoid Arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, swelling and loss of joint function. This study will assess how safe and effective upadacitinib is in treating RA when compared to adalimumab in adult participants with inadequate response or intolerance to one TNF-inhibitor who are on a stable dose of methotrexate (MTX). Adverse events and change in disease activity will be assessed. Upadacitinib is an approved drug for the treatment of RA. This study is double-blinded means that neither the participants nor the study doctors will know who will be given upadacitinib and who will be given adalimumab. Study doctors put the participants in 1 of the 2 groups, called treatment arms randomly, to receive either upadacitinib or adalimumab. There is 1 in 2 chance that participants will receive adalimumab. Each group consists of 2 periods. Approximately 480 participants diagnosed with RA will be enrolled in approximately 250 sites across the world. Participants will receive the oral upadacitinib once daily and matching adalimumab placebo every other week, or the subcutaneous adalimumab every other week and matching upadacitinib placebo once daily during Period 1. Eligible participants will continue to receive same study treatment in Period 2 as assigned in Period 1 and will be followed for 30 days and 70 days. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, checking for side effects and completing questionnaires.

Study identification

NCT ID
NCT05814627
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
487 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2023 (Actual)
Primary completion
Jul 15, 2026 (Actual)
Completion
Jul 15, 2026 (Actual)
Last update posted
Aug 14, 2026

2023 – 2026

United States locations

U.S. sites
85
U.S. states
30
U.S. cities
78
Facility City State ZIP Site status
AZ Arthritis and Rheumotology Research, PLLC - Flagstaff /ID# 253431 Flagstaff Arizona 86001-6299 —
Arizona Arthritis and Rheumatology Research - Glendale Office /ID# 255018 Glendale Arizona 85306-9802 —
Sun Valley Arthritis Center Ltd. /ID# 254654 Peoria Arizona 85381 —
Arizona Arthritis & Rheumatology Associates - East Bell Road /ID# 253432 Phoenix Arizona 85032 —
Arizona Arthritis & Rheumatology Associates - East Bell Road /ID# 255021 Phoenix Arizona 85032 —
Arizona Arthritis & Rheumatology Associates - Tucson /ID# 255017 Tucson Arizona 85704 —
Arthritis and Rheumatism Associates /ID# 254013 Jonesboro Arkansas 72401-6251 —
Providence - St. Jude Medical Center /ID# 252690 Fullerton California 92835 —
Newport Huntington Medical Group /ID# 252687 Huntington Beach California 92648-5994 —
Purushotham & Akther Kotha MD, Inc /ID# 252704 La Mesa California 91942 —
Valerius Medical Group & Research Center of Greater Long Beach, Inc /ID# 252692 Los Alamitos California 90720-5402 —
Rheumatology Center of San Diego /ID# 255038 San Diego California 92128-2549 —
Millennium Clinical Trials /ID# 252689 Thousand Oaks California 91360-3951 —
The Lundquist Institute at Harbor-UCLA Medical Center /ID# 252691 Torrance California 90502 —
Comprehensive Rheumatology Center /ID# 252688 Woodland Hills California 91364 —
University of Colorado Hospital /ID# 254617 Aurora Colorado 80045 —
Denver Arthritis Clinic /ID# 254058 Denver Colorado 80230 —
Tekton Research - Fort Collins - East Harmony Road /ID# 255036 Fort Collins Colorado 80528 —
Arthritis and Rheumatic Disease Specialties /ID# 260583 Aventura Florida 33180 —
Rheumatology Associates of South Florida (RASF) - Clinical Research /ID# 253733 Boca Raton Florida 33486 —
Bay Area Arthritis and Osteo /ID# 254046 Brandon Florida 33511 —
Believe Clinical Trial /ID# 262355 Coral Springs Florida 33065 —
International Medical Research /ID# 254651 Daytona Beach Florida 32117 —
Omega Research Debary, LLC /ID# 253735 DeBary Florida 32713-2260 —
Neoclinical Research /ID# 254622 Hialeah Florida 33016-1897 —
Gnp Research - Hollywood /ID# 273563 Hollywood Florida 33024 —
Life Clinical Trials /ID# 256061 Margate Florida 33063 —
Lakes Research, LLC /ID# 255023 Miami Florida 33014 —
HMD Research LLC /ID# 253732 Orlando Florida 32819 —
Millennium Research /ID# 253744 Ormond Beach Florida 32174 —
Vitalia Research /ID# 274213 Palm Beach Gardens Florida 33410 —
BayCare Medical Group /ID# 253799 St. Petersburg Florida 33705 —
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 254649 Tampa Florida 33606 —
Clinical Research Of West Florida - Tampa - North Howard Avenue /ID# 255264 Tampa Florida 33606 —
University of South Florida- Neuroscience Institute /ID# 253745 Tampa Florida 33613 —
Baycare Medical Group - Tampa /ID# 255268 Tampa Florida 33614 —
Atlanta Research Center For Rheumatology - Marietta /ID# 254623 Marietta Georgia 30060 —
Next Innovative Clinical Research - Chicago /ID# 273453 Chicago Illinois 60616 —
Deerbrook Medical Associates /ID# 254008 Libertyville Illinois 60048 —
OrthoIllinois /ID# 254057 Rockford Illinois 61114-4937 —
Greater Chicago Specialty Physicians /ID# 254000 Schaumburg Illinois 60195-3106 —
Clinic Of Dr. Robert Hozman/Clinical Investigation Specialists, Inc /ID# 253999 Skokie Illinois 60076 —
Willow Rheumatology and Wellness, PLLC /ID# 254712 Willowbrook Illinois 60527 —
Qualmedica Research - Evansville /ID# 254005 Evansville Indiana 47715-2813 —
Western KY Rheumatology /ID# 255026 Hopkinsville Kentucky 42240 —
Bluegrass Community Research /ID# 254653 Lexington Kentucky 40504 —
Ochsner Health Center - The Grove /ID# 254059 Baton Rouge Louisiana 70836 —
The Arthritis & Diabetes Clinic, Inc. /ID# 254014 Monroe Louisiana 71203 —
Rheumatology Associates PA - Portland /ID# 255014 Portland Maine 04102-2643 —
Beth Israel Deaconess Medical Center - Rheumatology /ID# 255029 Boston Massachusetts 02149-4903 —
AA Medical Research Center - Grand Blanc /ID# 254007 Grand Blanc Michigan 48439 —
Advanced Rheumatology, PC /ID# 256059 Okemos Michigan 48910 —
St. Paul Rheumatology, PA /ID# 255037 Eagan Minnesota 55121 —
Arthritis Associates /ID# 253992 Hattiesburg Mississippi 39402 —
Kansas City Physician Partners /ID# 255035 Kansas City Missouri 64151 —
Clinvest Research LLC /ID# 254054 Springfield Missouri 65807 —
Logan Health Research - Glacier View Research Institute - Rheumatology /ID# 253738 Kalispell Montana 59901 —
Physician Research Collaboration, LLC /ID# 254012 Lincoln Nebraska 68516 —
Dartmouth-Hitchcock Medical Center /ID# 253798 Lebanon New Hampshire 03756 —
Arthritis Rheumatic and Back Disease Associates. P.A. /ID# 255266 Voorhees Township New Jersey 08043 —
Arthritis and Osteoporosis Associates of New Mexico /ID# 252684 Las Cruces New Mexico 88011 —
NYU Langone Ambulatory Care Brooklyn Heights /ID# 254621 Brooklyn New York 11201 —
Joint And Muscle Research Institute /ID# 275128 Charlotte North Carolina 28204 —
Trinity Health Med Arts Clinic /ID# 254010 Minot North Dakota 58701 —
Paramount Medical Research and Consulting /ID# 254048 Middleburg Heights Ohio 44130 —
Rheumatology Associates of Oklahoma /ID# 253994 Oklahoma City Oklahoma 73116-7226 —
Clinical Research of Philadelphia, LLC /ID# 255025 Philadelphia Pennsylvania 19114 —
West Tennessee Research Institute /ID# 254620 Jackson Tennessee 38305 —
Arthritis and Rheumatology Research Institute, PLLC /ID# 254045 Allen Texas 75013-6147 —
Tekton Research, L.L.C /ID# 254004 Austin Texas 78745 —
Trinity Universal Research Associates - Carrollton /ID# 254648 Carrollton Texas 75007 —
Adriana Pop-Moody MD Clinic PA /ID# 255030 Corpus Christi Texas 78404 —
JPS Rheumatology Clinic /ID# 254050 Fort Worth Texas 76104-4917 —
Biopharma Informatic - Houston - Business Center Drive /ID# 254051 Houston Texas 77043 —
Accurate Clinical Research - Houston /ID# 254647 Houston Texas 77089-6142 —
Research Physicians Network, LLC /ID# 254053 Houston Texas 77089 —
R & H Clinical Research - 777 Katy /ID# 255024 Katy Texas 77450-2244 —
West Texas Clinical Research /ID# 253736 Lubbock Texas 79424 —
Trinity Universal Research Associates, Inc /ID# 253995 Plano Texas 75024-5283 —
Sun Research Institute /ID# 255019 San Antonio Texas 78215 —
Advanced Rheumatology of Houston /ID# 254003 The Woodlands Texas 77382 —
DM Clinical Research - Tomball /ID# 254001 Tomball Texas 77375 —
Rheumatology Clinic of Houston /ID# 254002 Tomball Texas 77377 —
Aurora Rheumatology and Immunotherapy Center /ID# 254049 Franklin Wisconsin 53132 —
Rheumatic Disease Center, LLP /ID# 254015 Glendale Wisconsin 53217 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05814627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05814627 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →